1621717-71-2

Upstream product

• 1275947-05-1 2-(3-chlorophenyl)-1-(3,4-dimethylphenyl)ethanone 

Downstream Products

• 1450736-57-8 4-{[4-(3-chlorophenyl)-5-(3,4-dimethyl-phenyl)pentyl]sulfinyl}benzaldehyde 
• 1621717-75-6 4-{[(4E)-4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pent-4-en-1-yl]sulfinyl}benzaldehyde 
• 1621913-33-4 1-(4-{[4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pentyl]sulfinyl}benzyl)azetidine-3-carboxylic acid 
• 1621717-73-4 methyl 4-{[4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pentyl]thio}benzoate 
• 1621717-72-3 methyl 4-{[4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)-5-hydroxypentyl]thio}benzoate 
• 1621717-87-0 3-[(4-{[(4E)-4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pent-4-en-1-yl]sulfinyl}benzyl)amino]propanoic acid 

Relevant academic research and scientific papers

ALKENE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS

The present invention relates to alkene derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS

The present invention relates to novel azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.